PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 1, 2022Frontiers in Immunology100 citationsOpen Access

Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications

TZTianyi ZhuJHJing HanYLYang Liu

Key Points

Key points are not available for this paper at this time.

Abstract

Osteosarcoma is a primary malignant tumor that tends to threaten children and adolescents, and the 5-year event-free survival rate has not improved significantly in the past three decades, bringing grief and economic burden to patients and society. To date, the genetic background and oncogenesis mechanisms of osteosarcoma remain unclear, impeding further research. The tumor immune microenvironment has become a recent research hot spot, providing novel but valuable insight into tumor heterogeneity and multifaceted mechanisms of tumor progression and metastasis. However, the immune microenvironment in osteosarcoma has been vigorously discussed, and the landscape of immune and non-immune component infiltration has been intensively investigated. Here, we summarize the current knowledge of the classification, features, and functions of the main infiltrating cells, complement system, and exosomes in the osteosarcoma immune microenvironment. In each section, we also highlight the complex crosstalk network among them and the corresponding potential therapeutic strategies and clinical applications to deepen our understanding of osteosarcoma and provide a reference for imminent effective therapies with reduced adverse effects.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zhu et al. (2022) studied this question.

synapsesocial.com/papers/69d862a333ca018b39ae39e8https://doi.org/10.3389/fimmu.2022.907550
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Screening of candidate key genes associated with human osteosarcoma using bioinformatics analysis2017 · 12 citations
  2. 2Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend2018 · 321 citations
  3. 3Phase II/III Trial of Etoposide and High-Dose Ifosfamide in Newly Diagnosed Metastatic Osteosarcoma: A Pediatric Oncology Group Trial2002 · 145 citations
  4. 4Tumor Syndromes Predisposing to Osteosarcoma2018 · 108 citations
  5. 5Phase II/III Trial of Etoposide and High-Dose Ifosfamide in Newly Diagnosed Metastatic Osteosarcoma: A Pediatric Oncology Group Trial2002 · 192 citations